Recall: FDA Sounds the Alarm on Hospira, Inc. (HSP) Blood Kits After 1 Patient Dies
8/16/2013 7:45:30 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
The FDA issues its highest-risk Class 1 recall for blood kits made by Hospira after 1 patient's death was deemed partly due to delayed treatment after the piercing pin in the kit punctured the outer wall of the blood bag. The FDA issued a Class I recall on blood kits made by Hospira (NYSE:HSP) after the medical device company reported that at least 1 patient's death was partially due to a delay in treatment caused by a punctured blood bad. The company warned healthcare providers that the piercing pins in certain of its blood kits may pierce through the blood bag's outer wall, leading to blood leaks and exposing healthcare providers to blood products.
Help employers find you! Check out all the jobs and post your resume.
comments powered by